Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elisa De Lazzari Bonaventura Clotet Sala Jose R. Arribas Esteban Ribera |
| Publication date | November 8, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |